Share Your Feedback

Pathos

AI

Biotechnology

11-50 employees

AI-enabled drug development built for patients

Founded in 2020

Chicago, Illinois, USA

11-50 employees

https://pathos.com

Funding

Late Stage

Current Stage

$365M

Recent Funding

$447M

Total Funding

Leadership Team

Ryan Fukushima

Co-Founder

Recent News

AstraZeneca says AI is raising its odds where most drugs fail

TheStreet.com

Pathos AI acquires majority stake in DeuterOncology

Pharma Letter

Pathos AI Acquires Majority Stake in DeuterOncology to Advance Next-Generation MET Inhibitor Identified by Pathos Foundry Platform

GlobeNewswire